Search bioRxivSearch

bioRxiv · 10.1101/459545

One Model to Rule Them All: An Integrative Approach to Matrix-Based Analyses in Neuroimaging Connectomics

Abstract

Network modeling in neuroimaging holds promise in probing the interrelationships among brain regions and potential clinical applications. Two types of matrix-based analysis (MBA) are usually seen in neuroimaging connectomics: one is the functional attribute matrix (FAM) of, for example, correlations, that measures the similarity of BOLD response patterns among a list of predefined regions of interest (ROIs). Another type of MBA involves the structural attribute matrix (SAM), e.g., describing the properties of white matter between any pair of gray-matter regions such as fractional anisotropy, mean diffusivity, axial and radial diffusivity. There are different methods that have been developed or adopted to summarize such matrices across subjects, including general linear models (GLMs) and various versions of graph theoretic analysis. We argue that these types of modeling strategies tend to be \"inefficient\" in statistical inferences and have many pitfalls, such as having strong dependence on arbitrary thresholding under conventional statistical frameworks.\n\nHere we offer an alternative approach that integrates the analyses of all the regions, region pairs (RPs) and subjects into one framework, called Bayesian multilevel (BML) modeling. In this approach, the intricate relationships across regions as well as across RPs are quantitatively characterized. This integrative approach avoids the multiple testing issue that typically plagues the conventional statistical analysis in neuroimaging, and it provides a principled way to quantify both the effect and its uncertainty at each region as well as for each RP. As a result, a unique feature of BML is that the effect at each region and the corresponding uncertainty can be estimated, revealing the relative strength or importance of each region; in addition, the effect at each RP is obtained along with its uncertainty as statistical evidence. Most importantly, the BML approach can be scrutinized for consistency through validation and comparisons with alternative assumptions or models. We demonstrate the BML methodology with a real dataset with 16 ROIs from 41 subjects, and compare it to the conventional GLM approach in terms of model efficiency, performance and inferences. Furthermore, we emphasize the notion of full results reporting through \"highlighting,\" instead of through the common practice of \"hiding.\" The associated program will be available as part of the AFNI suite for general use.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chen, G., Bürkner, P.-C., Taylor, P. A., Li, Z., Yin, L., Glen, D. R., Kinnison, J. K., Cox, R. W., Pessoa, L.. 2018-11-01. One Model to Rule Them All: An Integrative Approach to Matrix-Based Analyses in Neuroimaging Connectomics. https://doi.org/10.1101/459545

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience